Dr. Hecht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9440 Sw 91st St
Miami, FL 33176Phone+1 305-271-0099Fax+1 305-667-0239
Education & Training
- University of Miami/Jackson Health SystemResidency, Radiology-Diagnostic, 1971 - 1975
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1970 - 1971
- University of Miami Leonard M. Miller School of MedicineClass of 1970
Certifications & Licensure
- FL State Medical License 1973 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsChemical synthesis of lipophilic methylene blue analogues which increase mitochondrial biogenesis and frataxin levels.Indrajit Bandyopadhyay, Sandipan Roy Chowdhury, Nishant P. Visavadiya, Sidney M. Hecht, Omar M. Khdour
Data in Brief. 2018-08-31 - 8 citationsLipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.Omar M. Khdour, Indrajit Bandyopadhyay, Sandipan Roy Chowdhury, Nishant P. Visavadiya, Sidney M. Hecht
Bioorganic & Medicinal Chemistry. 2018-07-23 - 17 citationsOligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAsDiego Mastroeni, Jennifer Nolz, Omar M. Khdour, Shobana Sekar, Elaine Delvaux
Alzheimer's & Dementia. 2018-06-01
Grant Support
- Synthesis Of Bleomycin Group Antibiotics And AnaloguesNational Cancer Institute1998–2007
- Elaboration Of Modified Proteins Using Misacylated TrnasNational Cancer Institute1998–2007
- Interaction Of Bleomycin With RNA And DNANational Cancer Institute1998–2006
- Natural Products Discovery - Nuclear And Signaling TargeNational Cancer Institute2000–2004
- Mechanism And Inhibition Of Human DNA Topoisomerase INational Cancer Institute2000–2003
- Nuclear Targets For Natural Products Drug DiscoveryNational Cancer Institute1995–2002
- Core--Preparation, Storage, And Shipping Of Plant Extracts And AssaysNational Cancer Institute1995–2002
- Natural Products Discovery--Nuclear &Signaling TargetsNational Cancer Institute1995–2000
- Natural Prod Discovery--Nuclear &Signaling TargetsNational Cancer Institute1999
- Nucleic Acids As Therapeutic TargetsNational Cancer Institute1991–1997
- Nucleic Acids As Therapeutic Targets: Bleomycin, Antitumor, AntibioticNational Center For Research Resources1996
- Synthesis/Inhibition--P Falciparum DNA Polymerase DeltaNational Institute Of Allergy And Infectious Diseases1995
- Mechanism Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1994
- Synthetic Polypeptides VIA In Vitro Protein BiosynthesisNational Institute Of General Medical Sciences1990–1994
- Dept Chemistry, University Of VirginiaNational Cancer Institute1989–1994
- Mechanism-Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1989–1993
- Chemistry Of Activated BleomycinNational Cancer Institute1988–1991
- Synthesis Of Bleomycin Group AntibioticsNational Cancer Institute1985–1991
- Inhibition Of HIV ExpressionNational Institute Of Allergy And Infectious Diseases1988–1990
- Natural Products That Cleave DNANational Cancer Institute1985–1990
- Purchase Of General Electric Gn-500 NMR SpectrometerNational Center For Research Resources1988
- Nucleotide Replacements In Transfer RNANational Institute Of General Medical Sciences1985–1987
- Chemistry Of Activated BleomycinNational Cancer Institute1985–1987
- Purchase Of Varian Xl-300 NMR SpectrometerNational Center For Research Resources1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: